Table 1. Baseline Characteristics and Demographics of 24 Evaluable Patients.
| AGE (in years) | ||
| Median (Range) | 61 | (48–73) |
| SEX | ||
| Males | 12 | 50% |
| Females | 12 | 50% |
| RACE | ||
| Caucasian | 24 | 100% |
| PERFORMANCE STATUS | ||
| 0 | 18 | 75% |
| 1 | 5 | 21% |
| Missing | 1 | 4% |
| ELEVATED LDH | ||
| No | 9 | 38% |
| Yes | 15 | 63% |
| SITE(S) of DISTANT METASTASES | ||
| Bone | 4 | 17% |
| Brain | 1 | 4% |
| Liver | 20 | 83% |
| Lung | 8 | 33% |
| Distant nodes, skin, soft tissue | 4 | 17% |
| Other visceral | 3 | 13% |
| PRIOR SYSTEMIC TREATMENT FOR ADVANCED DISEASE | ||
| None | 20 | 83% |
| Chemotherapy | 4 | 17% |
| Biologic/Immunotherapy | 0 | 0% |
| TIME (in years) FROM INITIAL DIAGNOSIS TO FIRST DIAGNOSIS OF STAGE IV DISEASE | ||
| Median (Range) | 3.8 | (0–25) |